SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+12.43%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$565M
AUM Growth
+$565M
(-13%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-22.21%
Top 10 Holdings %
Top 10 Hldgs %
37.05%
Holding
162
New
40
Increased
21
Reduced
46
Closed
39
Top Buys
| 1 |
Gilead Sciences
GILD
|
$17.9M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$15.9M |
| 3 |
Biogen
BIIB
|
$13.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$8.86M |
| 5 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$6.96M |
Top Sells
| 1 |
Merck
MRK
|
$24.8M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$23M |
| 4 |
Johnson & Johnson
JNJ
|
$22.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$14.4M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 5.3% |
| 3 | Industrials | 3.85% |
| 4 | Energy | 1.97% |
| 5 | Consumer Discretionary | 1.17% |
